Min K. Park

Discovery of (2S)-N-[(1R)-2-[4-cyclohexyl-4-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperidinyl]-1-[(4-fluorophenyl)methyl]-2-oxoethyl]-4-methyl-2-piperazinecarboxamide (MB243), a potent and selective melanocortin subtype-4 receptor agonist

Brenda L. Palucki, Min K. Park, Ravi P. Nargund et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 42 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

Metabolic Activation of a 1,3-Disubstituted Piperazine Derivative:  Evidence for a Novel Ring Contraction to an Imidazoline

George A. Doss, Randall R. Miller, Zhoupeng Zhang et al. · Chemical Research in Toxicology · 2005 · 40 citations

Medicine, Medicinal Chemistry, Pharmacology +16

The Glial–Neuronal GRK2 Pathway Participates in the Development of Trigeminal Neuropathic Pain in Rats

Kyoung A Won, Min Ja Kim, Kui Ye Yang et al. · Journal of Pain · 2013 · 27 citations

Life Sciences, Neurobiology, Neuroscience +12

Discovery of Benzimidazole CYP11B2 Inhibitors with <i>in Vivo</i> Activity in Rhesus Monkeys

Scott B. Hoyt, Min K. Park, Clare London et al. · ACS Medicinal Chemistry Letters · 2015 · 24 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

2-Piperazinecarboxamides as potent and selective melanocortin subtype-4 receptor agonists

Brenda L. Palucki, Min K. Park, Ravi P. Nargund et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 22 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +8